Blog
Ligand (LGND) Q2 Revenue Jumps 15%
Ligand Pharmaceuticals (NASDAQ:LGND), a biopharma company known for earning royalties from a broad portfolio of drugs, announced results for the second quarter of 2025 on August 7, 2025. The company
Sanmina (SANM) Q3 2025 Earnings Call Transcript
Image source: The Motley Fool.
Monday, July 28, 2025, at 5 p.m. ET
Need a quote from one of our analysts? Email [email protected]
Source Fool.com
Kenvue (KVUE) Q2 Sales Drop 4%
Kenvue (NYSE:KVUE), the consumer health company best known for brands like Tylenol and Band-Aid, reported its earnings for the second quarter on August 7, 2025. The main news from the release
Palantir Just Hit $1 Billion in Quarterly Revenue. Here's How It Compares With the Magnificent Seven.
Palantir (NASDAQ: PLTR) has given shareholders plenty to celebrate once again.
The high-flying data analytics company blew away expectations for the second quarter. Its revenue growth accelerated
Qorvo (QRVO) Q1 2026 Earnings Call Transcript
Image source: The Motley Fool.
Tuesday, July 29, 2025, at 4:30 p.m. ET
Need a quote from one of our analysts? Email [email protected]
Source Fool.com
Here's Why This Nvidia Partner's Stock Soared in July
Shares in data center equipment company and Nvidia partner Vertiv Holdings (NYSE: VRT) rose by 13.4% in July, according to data provided by S&P Global Market Intelligence. The move comes in a month
Monte Rosa (GLUE) Q2 Revenue Jumps 394%
Monte Rosa Therapeutics (NASDAQ:GLUE), a biotechnology company developing molecular glue degrader therapies, announced results for the second quarter on August 7, 2025. The standout news was a sharp
Rocket Lab Stock Is Up Over 800% in 12 Months. Is It Too Late to Invest?
Investing in a stock that has accumulated significant returns in a short time period can be both exciting and nerve-wracking. On the one hand, you may be eager to jump on the bandwagon in the hopes
LQDT Reports Earnings
Liquidity Services (NASDAQ:LQDT), an online marketplace operator for surplus assets, reported its fiscal third quarter results on August 7, 2025. The quarter stood out with a record gross
Affiliated Managers (AMG) Q2 2025 Earnings Call
Image source: The Motley Fool.
Thursday, July 31, 2025, at 11 a.m. ET
Need a quote from one of our analysts? Email [email protected]
Source Fool.com
NCR (VYX) Fiscal Q2 EBITDA Jumps 20%
NCR (NYSE:VYX), a leading provider of digital commerce solutions for the retail and restaurant sectors, released its second quarter fiscal 2025 earnings on August 7, 2025. The company surpassed
Northern Oil and Gas (NOG) Q2 2025 Earnings Call
Image source: The Motley Fool.
Aug. 1, 2025 at 9 a.m. ET
Need a quote from one of our analysts? Email [email protected]
Source Fool.com
Constellation (CEG) Q2 Revenue Jumps 12%
Constellation Energy (NASDAQ:CEG), the largest producer of emissions-free energy in the United States, announced its financial results on August 7, 2025. The company delivered notable results, as
If You'd Invested $1,000 in Markel 10 Years Ago, Here's How Much You'd Have Today
Over the past decade, Markel (NYSE: MKL) has delivered a 116% return for investors, or about 8.1% annualized. That isn't exactly terrible performance, but when you consider that the S&P 500 has
Principal (PFG) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Tuesday, July 29, 2025, at 10 a.m. ET
For analyst quotes, email [email protected]
Source Fool.com
OPKO Health (OPK) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Thursday, July 31, 2025, at 4:30 p.m. ET
Need a quote from one of our analysts? Email [email protected]
Source Fool.com
NN (NNBR) Q2 Revenue Falls 12%
NN (NASDAQ:NNBR), a specialized manufacturer of high-precision industrial components for automotive, electrical, and medical sectors, reported its earnings for the quarter ended June 30, 2025, on
Zimmer Biomet (ZBH) Q2 Revenue Jumps 7%
Zimmer Biomet (NYSE:ZBH), an orthopedic medical technology company, reported its earnings on August 7, 2025. The company announced GAAP revenue of $2.077 billion, beating analyst estimates of $2.057
Black Diamond (BDTX) Q2 Loss Narrows 47%
Black Diamond Therapeutics (NASDAQ:BDTX), a biotechnology developer focused on precision cancer therapies, reported its financial results for the second quarter of fiscal 2025 on August 7, 2025. The
Patrick (PATK) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Thursday, July 31, 2025, at 10 a.m. ET
Need a quote from one of our analysts? Email [email protected]
Source Fool.com
Nuvalent (NUVL) Q2 R&D Up 65%
Nuvalent (NASDAQ:NUVL), a clinical-stage biotechnology company developing therapies for cancers driven by kinase mutations, released its second quarter 2025 earnings results on August 7, 2025. There
1 Reason I'm Watching Plug Power Stock in 2025
Plug Power (NASDAQ: PLUG) stock hasn't given investors much to celebrate in 2025. While the S&P 500 had risen 7.9% as of this writing, the hydrogen and fuel cell stock had plummeted 31% through Aug
Wheels Up (UP) Q2 Loss Narrows 14%
Wheels Up (NYSE:UP), a leading provider of on-demand private aviation and charter services, released its earnings for the second quarter of fiscal 2025 on August 7, 2025. The most notable news was a
IIPR Earnings Drop on Tenant Defaults
Innovative Industrial Properties (NYSE:IIPR), a real estate investment trust focused on properties leased to the regulated U.S. cannabis industry, released its earnings results for the second
Granite (GVA) Q2 EPS Jumps 27%
Granite Construction (NYSE:GVA), a leading provider of infrastructure solutions across the United States, released its Q2 2025 earnings on August 7, 2025. The company reported adjusted earnings per